Mariana Pereira Pinho
Postdoctoral Researcher
Tumor-specific T cell response
My research focuses on the analysis of T cells capable of recognizing and reacting to tumor antigens. Specifically, we are interested in evaluating the specificity and function of tumor-reactive CD8 T cells in breast cancer patients.
Key publications
-
Tumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.
Journal article
Pinho MP. et al, (2025), Cell Rep Med
-
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.
Journal article
COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58
-
Frequency determination of breast tumor-reactive CD4 and CD8 T cells in humans: unveiling the antitumor immune response.
Journal article
Pinho MP. et al, (2019), Oncoimmunology, 8
Recent publications
-
Tumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis.
Journal article
Pinho MP. et al, (2025), Cell Rep Med
-
Quality of Life Analysis in Patients Submitted to Dendritic Cell Vaccination for High Grade Gliomas: Update Report on a Phase II DC Trial
Preprint
Lepski GA. et al, (2025)
-
Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells
Journal article
Peres N. et al, (2024), International Journal of Molecular Sciences, 25, 5275 - 5275
-
A robust deep learning workflow to predict CD8 + T-cell epitopes.
Journal article
Lee CH. et al, (2023), Genome Med, 15
-
Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial
Journal article
Lepski G. et al, (2023), Cancers, 15, 1239 - 1239